SupplyManager℠  Become a Customer

  • #1087938
  • 9,355
  • Seqirus USA Inc #70461041810
Flucelvax® Quadrivalent 2018 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 4 Years of Age and Above Multiple Dose Vial 5 mL

Features
  • FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUCELVAX is approved for use in persons 4 years of age and older
  • FLUCELVAX QUADRIVALENT is standardized according to United States Public Health Service requirements for the 2017-2018 influenza season and is formulated to contain a total of 60 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA of each of the following four influenza strains: A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015-like virus); A/Singapore/GP2050/2015 (H3N2) (an A/Hong Kong/4801/2014 – like virus); B/Utah/9/2014 (a B/Phuket/3073/2013-like virus); B/Hong Kong/259/2010 (a B/Brisbane/60/08-like virus)
  • More …
Container Type
Multiple Dose Vial Prefilled Syringe
Volume
0.5 mL 5 mL
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #1087938
Manufacturer #70461041810
BrandFlucelvax® Quadrivalent 2018
ManufacturerSeqirus USA Inc
ApplicationFlu Vaccine
Container TypeMultiple Dose Vial
Dosage FormInjection
NDC Number70461041810
Storage RequirementsRequires Refrigeration
Strength60 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201608
UserIndicated For People 4 Years of Age and Above
Volume5 mL
Features
  • FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUCELVAX is approved for use in persons 4 years of age and older
  • FLUCELVAX QUADRIVALENT is standardized according to United States Public Health Service requirements for the 2017-2018 influenza season and is formulated to contain a total of 60 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA of each of the following four influenza strains: A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015-like virus); A/Singapore/GP2050/2015 (H3N2) (an A/Hong Kong/4801/2014 – like virus); B/Utah/9/2014 (a B/Phuket/3073/2013-like virus); B/Hong Kong/259/2010 (a B/Brisbane/60/08-like virus)
  • FLUCELVAX QUADRIVALENT 5 mL multi-dose vial formulation contains no antibiotics